74Software (74SW) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
30 Apr, 2026Executive summary
Q1 2026 revenue reached €182.7 million, up 10.0% organically year-over-year, driven by strong subscription growth and a shift toward recurring software revenue.
Both Axway and SBS contributed to growth, with Axway up 12.7% and SBS up 7.4% organically compared to Q1 2025.
Recurring product revenue was the main growth driver, supporting a more predictable and scalable business model.
Continued investment in AI-enabled software layers and innovation to support critical, regulated environments.
Financial highlights
Product revenue rose to €150.8 million, up 11.5% organically year-over-year.
Recurring revenue increased to €137.2 million, up 9.1% organically, while maintenance and support revenue declined due to migration to subscription models.
License revenue grew 44.1% organically; services revenue increased 3.1% organically.
Axway ARR reached €277.0 million (+8.8% YoY); SBS ARR reached €248.5 million (+8.9% YoY).
Net debt at quarter-end was €178.9 million, with cash and cash equivalents of €57.1 million.
Outlook and guidance
2026 guidance: organic revenue growth of 3–5%, margin on operating activities of 15–17%, and unlevered free cash flow around 10% of revenue.
Medium-term ambition: revenue close to €800 million and margin on operating activities ~20% by end-2028; €1 billion revenue target including selective acquisitions.
Q1 performance benefited from favorable phasing and should not be extrapolated for the full year.
Latest events from 74Software
- Organic revenue up 3.8% to €707.2m, margin 15.2%, ARR and recurring revenue at record highs.74SW
Q4 202525 Feb 2026 - H1 2024: 1.9% revenue growth, 18% subscription surge, and major acquisition on track.74SW
H1 20243 Feb 2026 - Q3 revenue up 14.9% organically, SBS integration boosts growth, 2025 targets reaffirmed.74SW
Q3 2024 TU18 Jan 2026 - €690m revenue, record margins, SaaS growth, and €1bn target set for the mid-term.74SW
H2 202416 Dec 2025 - Operating margin doubled and net profit turned positive on strong recurring revenue growth.74SW
H1 202516 Nov 2025 - Q3 revenue up 6.3% organically, guidance raised, and ARR growth remains strong.74SW
Q3 2025 TU30 Oct 2025 - 2024 revenue hit €690m with robust ARR growth and 2025 guidance set at €700m.74SW
Investor Presentation24 Jul 2025